Wilshire Technologies Relocates-Expands Headquarters To Princeton, New Jersey
10/05/2015
The firm offers a niche of value added products selected to serve the R&D, kilo-, pilot, commercial development and custom manufacturing requirements of the pharmaceutical, cosmetics and specialty chemical industries. “The move was necessitated by the increasing demand for the company's core offerings in technology development and custom manufacturing,” company officials said.
"This expansion will allow us to broaden our product portfolio and services while providing us the opportunity to serve our clients with even greater efficiency from a single location," said Kim Rodman, Director of Sales and Marketing.
"The entire company is excited to be growing so rapidly. The move, which will allow us to both expand our workforce and increase our personnel productivity, represents Wilshire Technologies' commitment to continue to build on the successes of the past 20 years," said Joe San Filippo, President.
Project Announcements
Piramal Pharma Solutions Expands Lexington, Kentucky, Operations
10/04/2024
G&H Decoys Plans Corning, Arkansas, Headquarters-Manufacturing Operations
10/04/2024
Britain-Based Ultimate Defense Technologies Establishes Billings, Montana, Operations
10/04/2024
Google Plans Dorchester County, South Carolina, Data Center Operations
10/04/2024
Sirius Analysis Plans Virginia Beach, Virginia, Headquarters
10/04/2024
South Korea-Based ILJIN Plans Auburn, Alabama, Manufacturing Operations
10/04/2024
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
Cold Storage: The Next Big Thing in Industrial Real Estate
Q3 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Challenge of Securing Sufficient Electrical Power for Battery Cell Plants
Q3 2024
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
Semiconductors’ Fragile Relationship With Water May Be Tested
Q3 2024